ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 269192 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 269192; 2) Community: the network communities that were significantly associated with the response to NSC 269192; 3) Molecule: the relationships between components within communities and NSC 269192; 4) MDR: the compounds that were significantly associated with the NSC 269192.

NSC Compound Enrichment Correlation
NSC 194124 Piperidinium, 1,1-didodecyl-3-methyl-, bromide 0.0187206825450448 0.36247353
NSC 105023 RUBIFLAVIN 0.0223138217461955 -0.0015053282
NSC 163062 TRIPTOLIDE 0.0223138217461955 0.0068617942
NSC 180260 Quinolinium, 1-methyl-4-[2-(2,4,5-trimethoxyphenyl)ethenyl]-, iodide 0.0223138217461955 0.46810697
NSC 208652 2,4-Quinazolinediamine, 5-chloro-6-[[(3,4-dichlorophenyl)amino]methyl]- 0.0223138217461955 -0.093124268
NSC 225112 2,4,6-Quinazolinetriamine, N(6)-[(3,4-dichlorophenyl)methyl]-N(6)-ethyl-5-methyl- 0.0223138217461955 -0.076553767
NSC 29182 Null 0.0223138217461955 0.091034753
NSC 3082 s-Triazine, 4,6-diamino-1-(m-bromophenyl)-1,2-dihydro-2,2-dimethyl-, hydrochloride (8CI) 0.0223138217461955 0.10740809
NSC 373355 Saframycin R 0.0223138217461955 0.20175515
NSC 403572 Acetophenone, 4'-bromo-2-hydroxy-, benzoate (8CI) 0.0223138217461955 -0.050205743
Total:110  Current:51    [First] [Prev] [Next] [Last]